0
Coronary Risk Factors Collection
The most recent journal, In the Clinic, and Summaries for Patients articles
Original Research |  7 May 2013
Action to Stop Smoking in Suspected Tuberculosis (ASSIST) in Pakistan: A Cluster Randomized, Controlled Trial
Kamran Siddiqi, PhD; Amir Khan, PhD; Maqsood Ahmad, MPhil; et al.
Ann Intern Med. 2013;158(9):667-675. doi:10.7326/0003-4819-158-9-201305070-00006
Original Research |  2 April 2013
Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults: A Cohort Study
Dariush Mozaffarian, MD, DrPH; Rozenn N. Lemaitre, PhD, MPH; Irena B. King, PhD; et al.
Ann Intern Med. 2013;158(7):515-525. doi:10.7326/0003-4819-158-7-201304020-00003
Original Research |  2 April 2013
Discontinuation of Statins in Routine Care Settings: A Cohort Study
Huabing Zhang, MD; Jorge Plutzky, MD; Stephen Skentzos, BA, BS; et al.
Ann Intern Med. 2013;158(7):526-534. doi:10.7326/0003-4819-158-7-201304020-00004
In the Clinic |  1 February 2011
The Polycystic Ovary Syndrome
Jennifer F. Wilson
Ann Intern Med. 2011;154(3):ITC2-1. doi:10.7326/0003-4819-154-3-201102010-01002
In the Clinic |  3 August 2010
Dyslipidemia
Laurie Kopin, MS, ANP; Charles Lowenstein, MD
Ann Intern Med. 2010;153(3):ITC2-1. doi:10.7326/0003-4819-153-3-201008030-01002
In the Clinic |  2 March 2010
Type 2 Diabetes
Sandeep Vijan, MD, MS
Ann Intern Med. 2010;152(5):ITC3-1. doi:10.7326/0003-4819-152-5-201003020-01003
ACP Journal Club |  16 April 2013
Metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD
Michael Tanner, MD, FACP
Ann Intern Med. 2013;158(8):JC4-. doi:10.7326/0003-4819-158-8-201304160-02004
ACP Journal Club |  16 April 2013
Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes
Saurav Chatterjee, MD; Sanjay Chatterjee, MD
Ann Intern Med. 2013;158(8):JC8-. doi:10.7326/0003-4819-158-8-201304160-02008
ACP Journal Club |  19 March 2013
Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs
Peter W. de Leeuw, MD
Ann Intern Med. 2013;158(6):JC7-. doi:10.7326/0003-4819-158-6-201303190-02007
Summaries for Patients
Summaries for Patients |  2 April 2013 FREE
Discontinuation of Statins
Ann Intern Med. 2013;158(7):I-40. doi:10.7326/0003-4819-158-7-201304020-00001
Summaries for Patients |  6 November 2012 FREE
How Do Older Diabetes Drugs Compare in Their Effects on Heart and Blood Vessel Disease?
Ann Intern Med. 2012;157(9):I-28. doi:10.7326/0003-4819-157-9-201211060-00001
Summaries for Patients |  20 March 2012 FREE
Dapagliflozin Treatment in Patients With Inadequately Controlled Type 2 Diabetes Despite the Use of Insulin
Ann Intern Med. 2012;156(6):I-44. doi:10.7326/0003-4819-156-6-201203200-00001
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)